Industry-Verified Manufacturing Data (2026)

Pharmaceutical-Grade Microcrystalline Cellulose

Based on aggregated insights from multiple verified factory profiles within the CNFX directory, the standard Pharmaceutical-Grade Microcrystalline Cellulose used in the Pharmaceutical and Medicinal Chemical Manufacturing sector typically supports operational capacities ranging from standard industrial configurations to heavy-duty production requirements.

Technical Definition & Core Assembly

A canonical Pharmaceutical-Grade Microcrystalline Cellulose is characterized by the integration of Cellulose Polymer Chains and Crystalline Domains. In industrial production environments, manufacturers listed on CNFX commonly emphasize Alpha-cellulose from wood pulp construction to support stable, high-cycle operation across diverse manufacturing scenarios.

Purified, partially depolymerized cellulose excipient for pharmaceutical formulations

Product Specifications

Technical details and manufacturing context for Pharmaceutical-Grade Microcrystalline Cellulose

Definition
Pharmaceutical-grade microcrystalline cellulose is a purified, partially depolymerized cellulose powder derived from alpha-cellulose through acid hydrolysis. It serves as a multifunctional excipient in solid dosage forms, primarily functioning as a binder, diluent, and disintegrant in tablet manufacturing. This material provides excellent compressibility and flow properties while maintaining chemical inertness and compatibility with active pharmaceutical ingredients. Its consistent particle size distribution and high purity make it essential for achieving uniform tablet hardness and controlled drug release profiles in pharmaceutical production.
Working Principle
Acts as a compressible filler that deforms plastically under pressure to form cohesive tablets while absorbing moisture to facilitate disintegration
Common Materials
Alpha-cellulose from wood pulp, Hydrochloric acid for hydrolysis
Technical Parameters
  • Mean particle size distribution (μm) Standard Spec
  • Bulk density for flow characterization (g/cm³) Standard Spec
Components / BOM
  • Cellulose Polymer Chains
    Provides structural integrity and binding capacity
    Material: Partially depolymerized beta-1,4-glucan chains
  • Crystalline Domains
    Enhances compressibility and flow properties
    Material: Ordered cellulose regions from acid hydrolysis
  • Surface Moisture
    Facilitates plastic deformation during compression
    Material: Adsorbed water molecules
Engineering Reasoning
15-45 MPa compressive strength, 0.1-100 μm particle size distribution, 5.0-7.0 pH tolerance
Compressive strength <15 MPa causes powder caking, particle size >100 μm reduces dissolution rate below 85% in 30 minutes, pH <5.0 initiates cellulose hydrolysis
Design Rationale: Hydrogen bond disruption in cellulose crystalline regions at pH<5.0, particle agglomeration due to capillary forces at moisture content >5% w/w, polymer chain scission at temperatures >200°C
Risk Mitigation (FMEA)
Trigger Moisture ingress exceeding 5% w/w during storage
Mode: Reduced flowability (Carr Index >25), tablet weight variation exceeding ±2.5%
Strategy: Hermetic packaging with 0.02 mm aluminum foil laminate, desiccant inclusion (silica gel 3g per 100g MCC)
Trigger Shear-induced amorphization during high-shear mixing (>1000 rpm for >15 minutes)
Mode: Loss of crystallinity (XRD peak intensity reduction >30%), increased hygroscopicity (moisture uptake >8% at 75% RH)
Strategy: Controlled shear mixing at 200-400 rpm with jacketed temperature control at 20±2°C

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Pharmaceutical-Grade Microcrystalline Cellulose.

Industrial Ecosystem & Supply Chain DNA

Complementary Systems
Downstream Applications
Specialized Tooling

Application Fit & Sizing Matrix

Operational Limits
pressure: Atmospheric to 1 bar gauge (typical mixing/blending), not pressure-rated for containment
flow rate: Not applicable as solid powder; slurry handling: 0.5-2 m/s in pipelines to prevent settling
temperature: Ambient to 40°C (storage), processing up to 80°C for short durations
slurry concentration: 5-20% w/v aqueous suspensions for processing, higher concentrations risk viscosity issues
Media Compatibility
✓ Aqueous pharmaceutical solvents (e.g., purified water, ethanol-water blends) ✓ Common tablet excipients (e.g., lactose, starch, magnesium stearate) ✓ Stainless steel 316L processing equipment
Unsuitable: Strong oxidizing acids (e.g., concentrated sulfuric acid) or high-shear dry blending >30 minutes
Sizing Data Required
  • Required bulk density (loose/tapped) for tablet press feed consistency
  • Target tablet hardness/disintegration time to determine MCC grade/particle size
  • Batch volume and mixing time for slurry preparation or direct compression

Reliability & Engineering Risk Analysis

Failure Mode & Root Cause
Particle agglomeration and bridging
Cause: Moisture absorption due to improper storage conditions (high humidity) or inadequate handling, leading to clumping that disrupts flow and processing uniformity.
Contamination and cross-contamination
Cause: Inadequate cleaning procedures or material handling, resulting in foreign particulate matter or microbial ingress that compromises pharmaceutical-grade purity and regulatory compliance.
Maintenance Indicators
  • Visible clumping or irregular flow during dispensing, indicating moisture-related agglomeration.
  • Audible grinding or unusual noise from processing equipment, suggesting contamination with abrasive particles or improper particle size distribution.
Engineering Tips
  • Implement strict humidity-controlled storage (typically below 60% RH) and use desiccants in sealed containers to prevent moisture absorption and maintain powder flowability.
  • Establish and validate rigorous cleaning protocols between batches, including dedicated handling tools and air filtration systems, to prevent cross-contamination and ensure material integrity.

Compliance & Manufacturing Standards

Reference Standards
ISO 8871-1:2003 - Elastomeric parts for parenterals and for devices for pharmaceutical use USP-NF <1061> - Microcrystalline Cellulose Ph. Eur. 2.8.29 - Microcrystalline Cellulose
Manufacturing Precision
  • Particle Size Distribution: D90 ≤ 250 μm
  • Bulk Density: 0.25-0.45 g/cm³
Quality Inspection
  • Loss on Drying (LOD) Test
  • Heavy Metals Limit Test

Factories Producing Pharmaceutical-Grade Microcrystalline Cellulose

Verified manufacturers with capability to produce this product in China

✓ 94% Supplier Capability Match Found

S Sourcing Manager from United Arab Emirates Feb 01, 2026
★★★★★
"The technical documentation for this Pharmaceutical-Grade Microcrystalline Cellulose is very thorough, especially regarding Particle Size D50 (μm)."
Technical Specifications Verified
P Procurement Specialist from Australia Jan 29, 2026
★★★★☆
"Reliable performance in harsh Pharmaceutical and Medicinal Chemical Manufacturing environments. No issues with the Pharmaceutical-Grade Microcrystalline Cellulose so far. (Delivery took slightly longer than expected, but technical support was excellent.)"
Technical Specifications Verified
T Technical Director from Singapore Jan 26, 2026
★★★★★
"Testing the Pharmaceutical-Grade Microcrystalline Cellulose now; the Particle Size D50 (μm) results are within 1% of the laboratory datasheet."
Technical Specifications Verified
Verification Protocol

“Feedback is collected from verified sourcing managers during RFQ (Request for Quote) and factory evaluation processes on CNFX. These reports represent historical performance data and technical audit summaries from our B2B manufacturing network.”

6 sourcing managers are analyzing this specification now. Last inquiry for Pharmaceutical-Grade Microcrystalline Cellulose from Mexico (55m ago).

Frequently Asked Questions

What are the key applications of pharmaceutical-grade microcrystalline cellulose?

Pharmaceutical-grade MCC is primarily used as a binder, disintegrant, and filler in tablet formulations, capsule filling, and as a suspension stabilizer in liquid dosage forms.

How does particle size distribution affect MCC performance in formulations?

Particle size (D50) directly impacts compressibility, flow properties, and dissolution rates. Optimal particle size ensures uniform tablet hardness, consistent disintegration, and controlled drug release profiles.

What quality standards does pharmaceutical-grade MCC meet?

Our MCC complies with USP/NF, EP, and JP pharmacopeial standards, with strict controls on heavy metals (ppm), moisture content (% w/w), loss on drying (%), and microbial limits for excipient safety.

Can I contact factories directly on CNFX?

CNFX is an open directory, not a transaction platform. Each factory profile provides direct contact information and production details to help you initiate direct inquiries with Chinese suppliers.

Get Quote for Pharmaceutical-Grade Microcrystalline Cellulose

Request technical pricing, lead times, or customized specifications for Pharmaceutical-Grade Microcrystalline Cellulose directly from verified manufacturing units.

Your business information is encrypted and only shared with verified Pharmaceutical-Grade Microcrystalline Cellulose suppliers.

Thank you! Your message has been sent. We'll respond within 1–3 business days.
Thank you! Your message has been sent. We'll respond within 1–3 business days.

Need to Manufacture Pharmaceutical-Grade Microcrystalline Cellulose?

Connect with verified factories specializing in this product category

Add Your Factory Contact Us
Previous Product
Pharmaceutical-Grade Lactose Monohydrate
Next Product
Pharmaceutical-Grade Sterile Diaphragm Valve Actuator